1 – 10 of 62
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2018
- Translational study reveals a two-faced role of RBM3 in pancreatic cancer and suggests its potential value as a biomarker for improved patient stratification
- Significance of poor performance status after resection of colorectal liver metastases
- Expression and prognostic significance of human epidermal growth factor receptors 1, 2 and 3 in oesophageal and gastric adenocarcinomas preneoadjuvant and postneoadjuvant treatment
- Expression of programmed cell death protein 1 (PD-1) and its ligand PD-L1 in colorectal cancer : Relationship with sidedness and prognosis
- A translational effort to identify prognostic and predictive biomarkers in pancreatic cancer among RBM3-regulated genes
- High risk of hypogonadism in young male cancer survivors
- Relationship between mismatch repair immunophenotype and long-term survival in patients with resected periampullary adenocarcinoma
- 2017
- The impact of neoadjuvant chemotherapy on skeletal muscle depletion and preoperative sarcopenia in patients with resectable colorectal liver metastases
- The integrative clinical impact of tumor-infiltrating T lymphocytes and NK cells in relation to B lymphocyte and plasma cell density in esophageal and gastric adenocarcinoma
- High RBM3 expression is associated with an improved survival and oxaliplatin response in patients with metastatic colorectal cancer